Announcements Trials

Browse Landscape

Status

Recruiting 6 Unknown 1 Terminated 1 Completed 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 5 Head and Neck Neoplasms 4 Prostatic Neoplasms 3 Urinary Bladder Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Esophageal Squamous Cell Carcinoma 2 Carcinoma, Hepatocellular 2 Brain Neoplasms 2 Thyroid Nodule 1 Spinal Cord Tumor of Cervical Spine 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Retinoblastoma 1 Rectal Neoplasms 1 Pelvic Neoplasms 1 Pathologic Complete Response 1 Parotid Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms 1 Multiple Pulmonary Nodules 1 Mouth Neoplasms 1 Lymphoma 1 Lymphatic Metastasis 1 Lung Neoplasms 1 Glioma 1 Esophageal Neoplasms 1 Disease 1 Colonic Neoplasms 1 Carcinoma, Squamous Cell 1

Interventions

Gemcitabine 78 Fluorouracil 27 Oxaliplatin 24 130-nm albumin-bound paclitaxel 24 Leucovorin 18 Capecitabine 15 Albumin-Bound Paclitaxel 15 S 1 (combination) 14 Taxes 12 Irinotecan 11 pembrolizumab 9 folfirinox 9 Radiosurgery 9 Radiotherapy 7 Drug Therapy 7 Cisplatin 7 irinotecan sucrosofate 6 Pancreaticoduodenectomy 5 Paclitaxel 5 Injections 5 Docetaxel 5 Blood Specimen Collection 5 apatinib 4 Radiofrequency Ablation 4 Radiation 4 Biopsy 4 tislelizumab 3 rubitecan 3 nimotuzumab 3 camrelizumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Pancreatic Neoplasms × Magnetic Resonance Imaging × Clear all

NCT04883450 2024-01-16

PRO-TECT

Kaiser Permanente

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡